Effective treatment with imatinib for acute B-lymphoblastic leukaemia with EBF1-PDGFRB fusion

Saved in:
Bibliographic Details
Published inAnnals of hematology Vol. 100; no. 5; pp. 1329 - 1331
Main Authors Horiuchi, Mirei, Yoshida, Masahiro, Yamasaki, Kai, Sakagami, Ryoko, Aoyama, Takane, Tatsumi, Naoko, Tsutsumi, Minako, Nakaya, Yosuke, Fuseya, Hoyuri, Yoshimura, Takuro, Hayashi, Yoshiki, Nakao, Takafumi, Yamane, Takahisa
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2021
Springer Nature B.V
Subjects
Adult
Bone Marrow - metabolism
Bone Marrow - pathology
Combined Modality Therapy
Cord Blood Stem Cell Transplantation
Hematology
Humans
Imatinib Mesylate - therapeutic use
Letter to the Editor
Male
Medicine
Medicine & Public Health
Oncogene Proteins, Fusion - genetics
Oncology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Receptor, Platelet-Derived Growth Factor beta - genetics
Trans-Activators - genetics
Treatment Outcome
Young Adult
Online AccessGet full text

Cover

More Information
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-020-04332-8